Editorial: Innovative strategies for overcoming resistance in tumor angiogenesis therapies

Résumé

cohort. The authors call for the development of predictive biomarkers and novel drug combinations to further enhance outcomes.In conclusion, the contributions to this Special Topic section underscore the dynamic and multifaceted nature of resistance to tumour angiogenesis therapies. By identifying new molecular targets, validating innovative combination therapies, and emphasising the significance of patient stratification, these studies provide guidance for developing more effective and sustainable antiangiogenic strategies. Overcoming resistance will require continued collaboration across disciplines, integration of emerging scientific insights, and a steadfast commitment to patient-centred care.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0